Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice1

The understanding of the mechanisms underlying eosinophil recruitment in vivo may aid in the development of novel strategies for the treatment of allergic disorders. In this study, we investigated the role of chemokines in the cascade of events leading to eosinophil recruitment in a stem cell factor (SCF)- and leukotriene B4 (LTB4)-dependent allergic pleurisy model in mice. The intrapleural administration of the eosinophil-active chemokines eotaxin, RANTES, and macrophage-inflammatory protein 1α (MIP-1α) induced a time- and dose-dependent eosinophil recruitment. Pretreatment with anti-eotaxin, but not anti-RANTES or anti-MIP-1α, blocked the recruitment of eosinophils following Ag challenge of sensitized animals, and significant eotaxin immunoreactivity was detected in the pleural cavity of these animals. Similarly, only the anti-eotaxin inhibited the eosinophil recruitment induced by injection of SCF in naive animals. However, blockade of SCF did not inhibit the release of eotaxin after Ag challenge of sensitized mice. Akin to its effects on SCF and in the allergic reaction, eotaxin-induced eosinophil recruitment was blocked by the LTB4 receptor antagonist CP105696. Nevertheless, SCF, but not eotaxin, appeared to regulate the endogenous release of LTB4 after Ag challenge. Finally, we show that low doses of eotaxin synergized with LTB4 to induce eosinophil recruitment in the pleural cavity. Overall, the present results show that eotaxin and SCF-induced LTB4 cooperate to induce eosinophil recruitment into sites of allergic inflammation. Cooperation between inflammatory mediators must be an important phenomenon in vivo, explaining both the ability of lower concentrations of mediators to induce a full-blown functional response and the effectiveness of different strategies at inhibiting these responses.

[1]  D. C. Cara,et al.  Mechanisms underlying eosinophil trafficking and their relevance in vivo. , 2000, Histology and Histopathology.

[2]  D. C. Cara,et al.  Stem Cell Factor Plays a Major Role in the Recruitment of Eosinophils in Allergic Pleurisy in Mice Via the Production of Leukotriene B41 , 2000, The Journal of Immunology.

[3]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[4]  C. Serhan,et al.  Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.

[5]  C. Hogaboam,et al.  Chemokines and asthma: redundancy of function or a coordinated effort? , 1999, The Journal of clinical investigation.

[6]  P. Poubelle,et al.  Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit. , 1999, Journal of immunology.

[7]  E. Allenspach,et al.  Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. , 1999, Journal of immunology.

[8]  G. Yu,et al.  Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.

[9]  M. Lindsay,et al.  Pharmacology of the eosinophil. , 1999, Pharmacological reviews.

[10]  D. Taub,et al.  Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. , 1999, Journal of immunology.

[11]  A. Proudfoot,et al.  The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions , 1999, International Archives of Allergy and Immunology.

[12]  M. Teixeira,et al.  Priming and induction of eosinophil trafficking in guinea‐pig cutaneous inflammation by tumour necrosis factor α , 1998, British journal of pharmacology.

[13]  M. Burdick,et al.  Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. , 1998, Journal of immunology.

[14]  M. Perretti,et al.  Resident mast cells are important for eotaxin‐induced eosinophil accumulation in vivo , 1998, Journal of leukocyte biology.

[15]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[16]  M. Laviolette,et al.  Characteristics of leukotriene biosynthesis by human granulocytes in presence of plasma. , 1998, Biochimica et biophysica acta.

[17]  D. Wilcox,et al.  Effect of mast cell deficiency and leukotriene inhibition on the influx of eosinophils induced by eotaxin , 1997, Journal of leukocyte biology.

[18]  A. Proudfoot,et al.  The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.

[19]  S. Kunkel,et al.  Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. , 1997, The Journal of clinical investigation.

[20]  M. Perretti,et al.  Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. , 1997, Journal of immunology.

[21]  J. Westwick,et al.  Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. , 1997, Journal of immunology.

[22]  M. Lindsay,et al.  Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. , 1997, Blood.

[23]  M. Perretti,et al.  A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment , 1997, British journal of pharmacology.

[24]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[25]  M. Cybulsky,et al.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.

[26]  M. Conklyn,et al.  Characterization of the pharmacological profile of the potent LTB4 antagonist CP‐105,696 on murine LTB4 receptors in vitro. , 1996, British journal of pharmacology.

[27]  M. Montjovent,et al.  Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.

[28]  M. Sticherling,et al.  Role of eosinophil‐chemotactic C‐C chemokines in cutaneous inflammation , 1996, Journal of leukocyte biology.

[29]  A. Luster,et al.  Molecular characterization of two murine eosinophil beta chemokine receptors. , 1995, Journal of immunology.

[30]  M. Teixeira,et al.  Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. , 1995, Trends in pharmacological sciences.

[31]  E. Pettipher,et al.  The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. , 1995, The Journal of pharmacology and experimental therapeutics.

[32]  R. Strieter,et al.  Macrophage inflammatory protein‐1α influences eosinophil recruitment in antigen‐specific airway inflammation , 1995 .

[33]  M. Teixeira,et al.  Effect of a 5‐lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea‐pig , 1994, British journal of pharmacology.

[34]  A. Shock,et al.  Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea‐pig skin , 1994, British journal of pharmacology.

[35]  R. Alam,et al.  Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. , 1994, Journal of immunology.

[36]  R. L. Maas,et al.  Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. , 1982, Journal of immunology.

[37]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[38]  A. Kay,et al.  Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. , 1991, The American review of respiratory disease.